Remdesivir Active Not Recruiting Phase 3 Trials for Coronavirus Disease 2019 (COVID‑19) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04610541REMdesivir-HU Clinical Study and Severe Covid-19 Patients
NCT04640168Adaptive COVID-19 Treatment Trial 4 (ACTT-4)